KA
GSK icon

Kozak & Associates’s GSK GSK Stock Holding History

Kozak & Associates’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.95K Hold
155
– – ﹤0.01% 280
2026
Q1 		$9.14K Hold
155
– – ﹤0.01% 272
2025
Q4 		$7.81K Hold
155
– – ﹤0.01% 272
2025
Q3 		$7.37K Buy
+155
New +$6.05K ﹤0.01% 281
2023
Q4 		– Sell
-112
Closed -$4.11K – 384
2023
Q3 		$4.11K Buy
+112
New +$3.98K ﹤0.01% 300

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Kozak & Associates's GSK Position: Q2 2026 in Review

Kozak & Associates held its GSK (GSK) position steady in Q2 2026 at 155 shares worth $7.95K. The position accounts for ﹤0.01% of the portfolio, ranked #280.

Kozak & Associates first reported a position in GSK in Q3 2023 and has held it in 5 quarters since. The position peaked at $9.14K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Kozak & Associates held 155 shares of GSK worth $7.95K as of Q2 2026.
  • Kozak & Associates left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #280 holding.
  • Kozak & Associates first reported a position in GSK in Q3 2023 and has held it in 5 quarters since.
  • Kozak & Associates's GSK position peaked at $9.14K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.